Schabacker Marcus 4

What Happened
Marcus Schabacker, a director of Enveric Biosciences, received an award of 18,518 restricted shares (transaction code A) on 2026-06-01. The grant is reported at a price of $0.00 (no cash paid) and is an issuance of restricted stock rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-01; Form 4 filed: 2026-06-03 (timely filing).
• Shares granted: 18,518 restricted common shares; reported price per share: $0.00.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote: Grant made under Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan; shares vest per the Plan and the reporting person's restricted stock award agreement.
• Transaction type: Award/grant of restricted stock (code A). Not a sale, purchase for cash, option exercise, or gift.

Context
Restricted stock awards are a form of compensation and typically vest over time, which limits immediate sale. Such grants are common for directors and executives and reflect compensation decisions by the company rather than a direct open-market endorsement or rejection of the stock.